Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec SE    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on EVOTEC SE
01/20/21 | 12:00pm Unicredit & KeplerCheuvreux German Corporate Conference
03/11/21 BioCapital Europe Conference
03/30/21 Jahr 2020 Ergebnisveröffentlichung (geplant)
05/18/21 Q1 2021 Ergebnisveröffentlichung (geplant)
Past events on EVOTEC SE
01/13/21 Commerzbank German Investment Conference
01/12/21 | 01:30pm JP Morgan Healthcare Conference
12/02/20 | 04:00pm Berenberg European Conference
11/24/20 Kempen Benelux Conference
Upcoming sector events for EVOTEC SE
01/21/21 BIOCON LIMITED : Q3 2021 Earnings Release
01/21/21 | 05:00am SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
01/27/21 LONZA GROUP LTD : FY 2020 Earnings Release
01/31/21 TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
More events
Past sector events for EVOTEC SE
01/19/21 | 09:30pm UNITED THERAPEUTICS CORPORATION : Tyvaso Study Results Call
01/19/21 AKESO, INC. : R&D Day
01/15/21 GUARDANT HEALTH, INC. : American society of clinical oncology gastrointestinal cancers symposium - abstract no : #423
01/15/21 GUARDANT HEALTH, INC. : American society of clinical oncology gastrointestinal cancers symposium - abstract no : tps #148
Annual publications
Annual results201520162017201820192020 (e)
Sales
M €
Released
Forecast
Spread
128
125
2,3%
165
157
5,1%
258
247
4,4%
375
370
1,5%
446
430
3,9%

482
Operating income
(EBITDA)
M €
Released
Forecast
Spread
8,69
14,7
-41%
36,2
29,0
25%
58,0
54,1
7,2%
95,5
88,0
8,5%
123
114
8,4%

105
Operating profit
(EBIT)
M €
Released
Forecast
Spread
11,6
12,6
-7,3%
31,3
20,6
52%
37,5
38,1
-1,7%
77,5
64,8
20%
62,6
59,7
4,8%

49,0
Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread
12,5
12,3
1,7%
33,0
18,6
77%
26,3
33,1
-20%
72,0
60,5
19%
56,6
51,0
11%

31,7
Net income
M €
Released
Forecast
Spread
16,5
11,3
46%
27,5
13,2
109%
24,3
26,7
-9,3%
84,2
61,1
38%
38,1
33,0
15%

19,4
EPS
Released
Forecast
Spread
0,12
0,08
42%
0,20
0,09
130%
0,16
0,19
-16%
0,56
0,39
45%
0,25
0,22
14%

0,13
Announcement Date03/22/201603/28/201703/28/201803/28/201903/26/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q42020 Q12020 Q22020 S12020 Q32020 Q4 (e)
Sales
M €
Released
Forecast
Spread
125
109
15%
119
114
4,7%
112
109
2,4%
231
226
2,0%
129
120
7,6%

116
Operating income
(EBITDA)
M €
Released
Forecast
Spread
29,9
23,3
29%
30,0
30,0
0,01%
17,3
18,0
-4,1%
47,3
50,8
-7,0%
29,7
31,1
-4,6%

25,0
Operating profit
(EBIT)
M €
Released
Forecast
Spread
16,2
10,1
60%
16,1
15,0
7,3%
2,82
4,20
-33%
18,9
22,6
-16%
16,4
17,1
-4,2%

3,00
Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread
12,8
5,60
129%









1,00
Net income
M €
Released
Forecast
Spread
8,36
7,40
13%
22,2
8,80
153%
-9,82
2,90
-439%


-1,41
5,10
-128%

4,00
EPS
Released
Forecast
Spread
0,05
0,05
0,00%
0,11
0,06
83%
-0,07
0,02
-450%


-0,01
0,03
-133%

0,03
Announcement Date03/26/202005/14/202008/12/202008/12/202011/12/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise